- are in
clinical development.
Medigene is a
German biotechnology company founded in 1994 as a spin-off from the
Munich Gene Center. In 2000, the company...
- T-cell
receptor technology.
Immunocore was
founded in 2008 as a
spinout of
MediGene AG,
which acquired Avidex in 2006. The core
technology was spun out of...
-
hosts many biotech-companies, like ADVA
Optical Networking, GPC Biotech,
MediGene and MorphoSys. In addition, the Max
Planck Institute of
Biochemistry and...
-
developed by
Medigene Inc. and
licensed for
development by
Catherex Inc. in 2010. NV1020 has a
deletion of just one copy of the ICP34.5
gene and ICP6 is...
- in
animals and humans. By 1999, the
inventor had
granted a
license to
MediGene AG (Martinsried, Germany) for
further development as a drug
against congestive...
- for $420M". GEN. 5 June 2007.
Retrieved 27
January 2025. "
Medigene AG:
Amgen acquires Medigene spin-off Catherex".
Fierce Biotech. 21
December 2015. Retrieved...
-
GroupPharma GmbH Janssen-Cilag GmbH
Lilly Pharma Holding GmbH
Lundbeck GmbH
MediGene AG
Merck KGaA
Merck & Co
named MSD
Sharp &
Dohme on vfa
website Mundipharma...
- and from 1998 to 1999 as vice
president of
research and development,
MediGene AG, Martinsried, Germany.
Gissmann was a
member of the DKFZ
board of trustees...
- Proto-oncogene c-KIT is the
gene encoding the
receptor tyrosine kinase protein known as tyrosine-protein
kinase KIT, CD117 (cluster of differentiation...
- CYP2B6, CYP2C8, CYP2C19, CYP2A6, CYP3A5, CYP1E1, and the CYP2E subfamily. The
gene expression of
these isoenzymes is
regulated by
human pregnane receptor X...
